Hiv Prevention
-
{
- All
- News
-
New HIV Vaccine Offers Strong Protection Against The Virus: What The Study Found
Instead of targeting HIV directly, the new vaccine focuses on training the immune system to produce powerful antibodies capable of recognising many different HIV strains.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
Cambodia Hits 95-95-95 HIV Targets, On Track To End AIDS By 2030: Health Minister
Phnom Penh, May 30 (IANS) Cambodia achieved its 95-95-95 HIV treatment targets last year, and is on track to eliminate AIDS as a public health threat by 2030, the country's Minister of Health Chheang Ra has said.
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
Global HIV Response Facing Worst Setback In Decades Amid 2025 Funding Cuts: New Report
A new report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global HIV response has suffered its most significant setback in decades, urging reliance on solidarity, resilience, investment and
-
Every-2-Month HIV Prevention Breakthrough Shot Approved By UK: Will India Follow?
The UK has approved a long-acting injection for HIV prevention, administered every two months. Experts say it marks a major step in public-health tools, but complex issues of access and cost raise questions for India.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Long-Term HIV Preventative Treatment To Be Accessible In Low-Income Nations
A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur.
-
Bill Gates Invests $140 Million In Groundbreaking New Technology For HIV Cure
Microsoft founder Bill Gates' charity foundation has invested USD 140 million in the development of HIV-preventing drug implants that could revolutionise the treatment of the life-threatening infection.
-
New Drug May Prevent HIV Transmission In Women, Kids
A new potent anti-HIV drug may effectively prevent vaginal and oral transmission of the deadly virus, scientists have shown in animal models.
-
HIV Pill Protects 100 Per Cent of Participants in Study
Researchers following over 600 people who took an HIV prevention pill for more than two years have found that 100 per cent of them remained free from the virus even in high-risk environments.
-
HIV Pill Protects 100 Per Cent of Participants in Study
Researchers following over 600 people who took an HIV prevention pill for more than two years have found that 100 per cent of them remained free from the virus even in high-risk environments.
-
Early Treatment can Prevent Transmission of HIV: Study
Starting antiretroviral treatment early against HIV is highly effective at preventing sexual transmission of the deadly virus in partners, a new study conducted in nine countries, including India, has found.
-
Mallika Sherawat meets Jackie Chan, again
Mallika Sherawat caught up with international action star Jackie Chan at the ongoing 65th Cannes International Film Festival.
-
New HIV Vaccine Offers Strong Protection Against The Virus: What The Study Found
Instead of targeting HIV directly, the new vaccine focuses on training the immune system to produce powerful antibodies capable of recognising many different HIV strains.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
Cambodia Hits 95-95-95 HIV Targets, On Track To End AIDS By 2030: Health Minister
Phnom Penh, May 30 (IANS) Cambodia achieved its 95-95-95 HIV treatment targets last year, and is on track to eliminate AIDS as a public health threat by 2030, the country's Minister of Health Chheang Ra has said.
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
Global HIV Response Facing Worst Setback In Decades Amid 2025 Funding Cuts: New Report
A new report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global HIV response has suffered its most significant setback in decades, urging reliance on solidarity, resilience, investment and
-
Every-2-Month HIV Prevention Breakthrough Shot Approved By UK: Will India Follow?
The UK has approved a long-acting injection for HIV prevention, administered every two months. Experts say it marks a major step in public-health tools, but complex issues of access and cost raise questions for India.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Long-Term HIV Preventative Treatment To Be Accessible In Low-Income Nations
A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur.
-
Bill Gates Invests $140 Million In Groundbreaking New Technology For HIV Cure
Microsoft founder Bill Gates' charity foundation has invested USD 140 million in the development of HIV-preventing drug implants that could revolutionise the treatment of the life-threatening infection.
-
New Drug May Prevent HIV Transmission In Women, Kids
A new potent anti-HIV drug may effectively prevent vaginal and oral transmission of the deadly virus, scientists have shown in animal models.
-
HIV Pill Protects 100 Per Cent of Participants in Study
Researchers following over 600 people who took an HIV prevention pill for more than two years have found that 100 per cent of them remained free from the virus even in high-risk environments.
-
HIV Pill Protects 100 Per Cent of Participants in Study
Researchers following over 600 people who took an HIV prevention pill for more than two years have found that 100 per cent of them remained free from the virus even in high-risk environments.
-
Early Treatment can Prevent Transmission of HIV: Study
Starting antiretroviral treatment early against HIV is highly effective at preventing sexual transmission of the deadly virus in partners, a new study conducted in nine countries, including India, has found.
-
Mallika Sherawat meets Jackie Chan, again
Mallika Sherawat caught up with international action star Jackie Chan at the ongoing 65th Cannes International Film Festival.
